Actionable news
All posts from Actionable news
Actionable news in KERX: Keryx Biopharmaceuticals, Inc.,

Keryx Biopharmaceuticals (KERX) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Keryx Biopharmaceuticals ( KERX) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Keryx Biopharmaceuticals as such a stock due to the following factors:

  • KERX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $18.4 million.
  • KERX has traded 480,010 shares today.
  • KERX is up 7% today.
  • KERX was down 5.2% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in KERX with the Ticky from Trade-Ideas. See the FREE profile for KERX NOW at Trade-Ideas More details on KERX: Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Currently there are 6 analysts that rate Keryx Biopharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Keryx Biopharmaceuticals has been 2.4 million shares per day over the past 30 days. Keryx has a market cap of $510.1 million and is part of the health care sector and drugs industry. The stock has a beta of 6.44 and a short float of 44.7% with 9.94 days to cover. Shares are down 67.5% year-to-date as of...